Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1966 3
1967 1
1968 4
1969 3
1970 3
1971 1
1972 2
1973 4
1974 11
1975 13
1976 4
1977 15
1978 15
1979 28
1980 30
1981 33
1982 44
1983 40
1984 59
1985 80
1986 60
1987 38
1988 25
1989 35
1990 37
1991 39
1992 44
1993 53
1994 53
1995 57
1996 42
1997 52
1998 57
1999 75
2000 45
2001 72
2002 57
2003 63
2004 100
2005 78
2006 96
2007 83
2008 102
2009 100
2010 116
2011 141
2012 161
2013 158
2014 157
2015 155
2016 150
2017 147
2018 156
2019 146
2020 179
2021 152
2022 149
2023 151
2024 145
2025 132
2026 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,940 results

Results by year

Filters applied: . Clear all
Page 1
Lyotropic liquid crystals for parenteral drug delivery.
Chavda VP, Dawre S, Pandya A, Vora LK, Modh DH, Shah V, Dave DJ, Patravale V. Chavda VP, et al. J Control Release. 2022 Sep;349:533-549. doi: 10.1016/j.jconrel.2022.06.062. Epub 2022 Jul 20. J Control Release. 2022. PMID: 35792188 Free article. Review.
The necessity for long-term treatments of chronic diseases has encouraged the development of novel long-acting parenteral formulations intending to improve drug pharmacokinetics and therapeutic efficacy. ...In this manuscript, we have consolidated and summarized the …
The necessity for long-term treatments of chronic diseases has encouraged the development of novel long-acting parenteral formulation …
Novel drug delivery systems for inflammatory bowel disease.
Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Yasmin F, et al. World J Gastroenterol. 2022 May 14;28(18):1922-1933. doi: 10.3748/wjg.v28.i18.1922. World J Gastroenterol. 2022. PMID: 35664964 Free PMC article. Review.
Novel drug delivery systems have been introduced to overcome several therapeutic obstacles and for localized drug delivery to target tissues. Enteric-coated microneedle pills, various nano-drug delivery techniques, prodrug syste …
Novel drug delivery systems have been introduced to overcome several therapeutic obstacles and for localized drug …
Nanoemulsion: Concepts, development and applications in drug delivery.
Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, Chourasia MK. Singh Y, et al. J Control Release. 2017 Apr 28;252:28-49. doi: 10.1016/j.jconrel.2017.03.008. Epub 2017 Mar 6. J Control Release. 2017. PMID: 28279798 Review.
These come across as ultrafine dispersions whose differential drug loading; viscoelastic as well as visual properties can cater to a wide range of functionalities including drug delivery. ...We attempt to explore varying intricacies, excipients, manufacturing …
These come across as ultrafine dispersions whose differential drug loading; viscoelastic as well as visual properties can cater to a …
Applications of Lipid-based Nanocarriers for Parenteral Drug Delivery.
Santonocito D, Puglia C. Santonocito D, et al. Curr Med Chem. 2022;29(24):4152-4169. doi: 10.2174/0929867329666220104111949. Curr Med Chem. 2022. PMID: 34983336 Review.
This review describes the use of lipid-based nanocarriers (LNCs) for the parenteral delivery of pharmaceutical actives. Firstly, the two generations of LNCs, namely solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), are explained in terms of …
This review describes the use of lipid-based nanocarriers (LNCs) for the parenteral delivery of pharmaceutical actives. Firstl …
Long-acting parenteral drug delivery systems for the treatment of chronic diseases.
Jindal AB, Bhide AR, Salave S, Rana D, Benival D. Jindal AB, et al. Adv Drug Deliv Rev. 2023 Jul;198:114862. doi: 10.1016/j.addr.2023.114862. Epub 2023 May 7. Adv Drug Deliv Rev. 2023. PMID: 37160247 Review.
However, the need for daily dosing can lead to nonadherence to the therapy, which can result in the recurrence of the disease. Long-acting parenteral drug delivery systems have the potential to improve the treatment of chronic conditions. ...The use of …
However, the need for daily dosing can lead to nonadherence to the therapy, which can result in the recurrence of the disease. Long-acting …
Enhancement strategies for transdermal drug delivery systems: current trends and applications.
Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Ramadon D, et al. Drug Deliv Transl Res. 2022 Apr;12(4):758-791. doi: 10.1007/s13346-021-00909-6. Epub 2021 Jan 20. Drug Deliv Transl Res. 2022. PMID: 33474709 Free PMC article.
Transdermal drug delivery systems have become an intriguing research topic in pharmaceutical technology area and one of the most frequently developed pharmaceutical products in global market. The use of these systems can overcome associated drawbacks o …
Transdermal drug delivery systems have become an intriguing research topic in pharmaceutical technology area and one of …
Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review.
Hörmann K, Zimmer A. Hörmann K, et al. J Control Release. 2016 Feb 10;223:85-98. doi: 10.1016/j.jconrel.2015.12.016. Epub 2015 Dec 14. J Control Release. 2016. PMID: 26699427 Review.
This size of oil droplets dispersed in a continuous water phase is a prerequisite for the parenteral, namely intravenous administration. Many parenteral nutrition and drug emulsions on the market confirm the safe use of NE over years. Parenteral …
This size of oil droplets dispersed in a continuous water phase is a prerequisite for the parenteral, namely intravenous administrati …
Parenteral drug delivery: a review.
Gulati N, Gupta H. Gulati N, et al. Recent Pat Drug Deliv Formul. 2011 May;5(2):133-45. doi: 10.2174/187221111795471391. Recent Pat Drug Deliv Formul. 2011. PMID: 21453250 Review.
To maintain a therapeutic effective concentration of the drug, it requires frequent injections which ultimately lead to patient discomfort. In parenteral drug delivery, major progress has been done in the field of formulation technologies so as to prov …
To maintain a therapeutic effective concentration of the drug, it requires frequent injections which ultimately lead to patient disco …
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery.
Bakrey H, Shivgotra R, Abdu A, Soni B, Shahtaghia NR, Jain SK, Thakur S. Bakrey H, et al. Curr Drug Targets. 2024;25(5):306-329. doi: 10.2174/0113894501284598240226102943. Curr Drug Targets. 2024. PMID: 38454772 Review.
Total Parenteral Nutrition (TPN) is a method of providing nutrients directly into the bloodstream for individuals who are unable to meet their nutritional needs through the normal digestive process or gastrointestinal system. ...This review focuses on the utilizatio …
Total Parenteral Nutrition (TPN) is a method of providing nutrients directly into the bloodstream for individuals who are unab …
In situ forming parenteral drug delivery systems: an overview.
Packhaeuser CB, Schnieders J, Oster CG, Kissel T. Packhaeuser CB, et al. Eur J Pharm Biopharm. 2004 Sep;58(2):445-55. doi: 10.1016/j.ejpb.2004.03.003. Eur J Pharm Biopharm. 2004. PMID: 15296966 Review.
Biodegradable injectable in situ forming drug delivery systems represent an attractive alternative to microspheres and implants as parenteral depot systems. ...For these reasons, a number of polymeric drug delivery systems w …
Biodegradable injectable in situ forming drug delivery systems represent an attractive alternative to microspheres and …
3,940 results